Peloton Equity, LLC, a healthcare-focused private equity firm, has closed its second fund Peloton Equity II, L.P. (“Fund II”) with $152.25 million in limited partner and general partner commitments
Fund II will seek to continue Peloton’s strategy of investing growth capital in innovative healthcare companies and partnering with management teams to achieve accelerated growth and value creation. Peloton invests across a wide range of healthcare sectors with a focus on differentiated companies that it believes are positioned to benefit from secular industry tailwinds. Three investments have been made out of the fund to date:
Based in Austin, TX, ClearSky Health is a leading provider of inpatient rehabilitation (IRF) and related post-acute care services to patients in need of intensive care following an acute event.
Based in Rochester, NY, AeroSafe Global is a provider of cold chain packaging and logistics solutions (cold-chain-as-a-service) to the pharmaceutical, biopharmaceutical, specialty pharmacy and medical device industries.
Based in Denver, CO, Friday Health Plans is a provider of consumer-oriented health plans to individuals and small groups in Colorado, Nevada, New Mexico and Texas.
With the close of Fund II, Peloton will have the capital available to make several new portfolio company investments and support follow on investments in its existing portfolio companies.
Peloton is also welcoming a group of five Operating Partners for Fund II. Tom Bailey, Kevin Hill, Ted Hull, Keith Longson and Albert Prast, who all bring experience and company-building know how that is complementary to Peloton’s investment team and specifically relevant to companies and sectors Fund II will target.
Source: Business Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.